Navigation Links
Reportlinker Adds Small Molecule Kinase Inhibitors Report
Date:9/8/2009

Astex Therapeutics Develops Structure of Cyclin Dependent Kinase 4 II-49

Astex Teams up with Cancer Research UK on Clinical Trials of AT9283 II-49

Astex Presents AT7519, a Cyclin Dependent Kinase Inhibitor II-49

Cell Biosciences Unveils First Kits for Oncoprotein Analysis II-50

Plexxikon Partners with Roche to Develop and Commercialize PLX5568 II-50

OSI Applies Additional NDA for Tarceva II-50

KAI and BMS Forms Global Alliance on KAI-9803 II-51

Kosan Biosciences Commences Phase II Trial for Alvespimycin II-51

Plexxikon Announces Commencement of Phase 1 PLX5568 Trial II-51

Exelixis Instigates Phase III XL184Trial II-51

Oncothyreon Commences Phase I PX-866 Clinical Trial II-52

Iressa As Efficient as Chemotherapy for Lung Cancer II-52

Iressa Proves Useful for Non-smoker Patients II-52

GPC Biotech Commence Enrollment in Phase 1 RGB-286638 Trial II-52

AVEO Commences Phase I Clinical Trials of AV-951 II-52

Onyx and Bayer Secure FDA and EC Approval for Nexavar(R) II-53

Product Patent Application for Iressa Rejected II-53

OSI Pharmaceuticals to Launch Tarceva(R) in Japan II-53

New Plk1 Kinase Inhibitor BI 2536 Developed II-54

Kinex Files IND Application for KX2-391 II-54

Wyeth Receives FDA Approval for TORISEL for Advanced Renal Cancer Treatment II-54

Nexavar Gets Approval from Swiss Authorities for Treatment of Kidney Cancer (Switzerland) II-54

5. RECENT INDUSTRY ACTIVITY II-55

Merck Agrees to Merge with Schering-Plough II-55

Pfizer Agrees to Acquire Wyeth II-55

S*BIO, Tragara Signs Exclusive Agreement II-55

GPC Biotech to Merge with Agennix II-55

Sanofi-Aventis to acquire Bipar Sciences II-56

Pfizer Takes Over Serenex II-56

Roche to Acquire Piramed II-56

Eli Lilly Acquires SGX Pharmaceuticals II-57

Takeda Acquires
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Reportlinker Adds Nanomedicine Report
2. Reportlinker Adds Proteomics: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
5. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
6. Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
7. Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
8. The Worlds Smallest Hero! Rexin-G, Targeted Therapy for Metastatic Cancers
9. AEterna Zentaris Discloses Preliminary Phase 2 Trial Results for Perifosine in Combination with Radiotherapy for Non-Small Cell Lung Cancer
10. Signostics Receives FDA Clearance for Worlds Smallest Ultrasound Product
11. PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... (PRWEB) May 21, 2015 Specialty ... audit and been admitted to BPA Worldwide as ... Worldwide will track audience data for Specialty Pharmacy ... , “By becoming a member of BPA ... to providing our clients with the most reliable, ...
(Date:5/21/2015)... Calif. , May 21, 2015  The ... Orrin Hatch (R-UT) and Amy Klobuchar ... Extensions Now Accelerating Cures & Treatments, or OPEN ... rare disease patient advocacy organizations, this bipartisan legislation ... and affordable medicines to rare disease patients by ...
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, Endetec, ... agreement with VWR to distribute TECTA™ B16, an ... 160 years of experience, VWR, a leading global ... production facilities, has cultivated a value proposition delivering ... enable science. Endetec’s TECTA™ B16, combines proven ...
Breaking Biology Technology:Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
... CHARENTON-LE-PONT, France, August 28 , - Hubert ... The Board of Directors of Essilor International today ... alongside Xavier Fontanet,Chief Executive Officer, and Philippe Alfroid, ... Centrale in Lille and holder of an MBA ...
... N.J., Aug. 27 BD (Becton,Dickinson and Company) (NYSE: ... that it would present at the following investor healthcare,conferences:, ... 4, 2008 1:30 p.m. EDT, Morgan Stanley ... 8:00 a.m. EDT, A live webcast of BD,s ...
... of,Directors, meeting today under the chairmanship of Albert Saporta, approved,STALLERGENES, half year consolidated financial statements:, (EUR millions) ... ... % ... ...
Cached Biology Technology:Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit 2Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit 3
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
(Date:4/9/2015)... SAN JOSE, Calif. , April 9, 2015 /PRNewswire/ ... of human interface solutions, announced today that it will ... 2015 on Thursday, April 23, 2015, after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:4/2/2015)... , April 2, 2015 At its ... Salt Lake City , the American College of ... five new directors to its Board.  Members of the ... ACMG and for forming and advancing its policies and ... genetics profession. "It,s an eventful time in ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... 28, 2008--As atmospheric CO2 levels rise, methods to mitigate ... in the July-August 2008 issue of Soil Science ... of soils as a C sink in different regions ... Rural Development (Canada), the National Institute of Agricultural Technology, ...
... researchers have developed a new technology that promises ... readily available non-food crops, such as Bermudagrass, switchgrass, ... ethanol from renewable biomass sources such as grasses ... large quantities," said Joy Peterson, professor of microbiology ...
... Strange things are happening in the lowland tropical forests ... fly is affecting the social behavior of a nocturnal ... which become workers. The finding by researchers from ... Institute is the first documented example of a parasite ...
Cached Biology News:Soil's carbon storage capacity investigated 2Soil's carbon storage capacity investigated 3New UGA biomass technology dramatically increases ethanol yield from grasses and yard waste 2New UGA biomass technology dramatically increases ethanol yield from grasses and yard waste 3A bee's future as queen or worker may rest with parasitic fly 2
... of Flight Mass Analyzer for superior sensitivity, mass accuracy, and resolving ... m/z, * Precursor ion selection range: 150 - 4000 m/z, * ... with internal reference, * Dynamic range: 4 orders of magnitude ... ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
Mouse polyclonal antibody to BTAF1 - BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)...
... combines Harvard Apparatuss best pump mechanism, a well ... of configuration options. A lookup table in the ... all the major manufacturers. A bright, two line ... from across the lab. All models have RS-232 ...
Biology Products: